Δημοσίευση

Daptomycin use in a neonate: serum level monitoring and outcome.

ΤίτλοςDaptomycin use in a neonate: serum level monitoring and outcome.
Publication TypeJournal Article
Year of Publication2010
AuthorsSarafidis, K., Iosifidis E., Gikas E., Tsivitanidou M., Drossou-Agakidou V., & Roilides E.
JournalAm J Perinatol
Volume27
Issue5
Pagination421-4
Date Published2010 May
ISSN1098-8785
Λέξεις κλειδιάAnti-Bacterial Agents, Daptomycin, Female, Gram-Positive Bacterial Infections, Humans, Infant, Newborn, Infant, Premature, Male, Treatment Outcome
Abstract

We present a case of successfully treated persistent bacteremia due to Gram-positive bacteria with daptomycin in a preterm neonate. Daptomycin was given at higher doses (6 mg/kg/dose) and shorter intervals (every 12 hours) than those recommended for adults with no adverse events. Peak and trough serum concentrations of daptomycin were 27.3 and 11.6 μg/mL [DOSAGE ERROR CORRECTED] at day 4 as well as 22.9 and 7.9 μg/mL [DOSAGE ERROR CORRECTED]at day 11 after initiation of treatment, respectively.

DOI10.1055/s-0029-1243370
Alternate JournalAm J Perinatol
PubMed ID20013573

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.